Dinoprostone

This classification denotes a prostaglandin analogue with the molecular formula C20H32O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K7Q1JQR04M, chemically known as u,12, 062 but generally known as dinoprostone, which bears US NIH Compound Identifier 158. European Medicines Agency schedules Dinoprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07195MIG. The term DINOPROSTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules dinoprostone in its Anatomical Therapeutic Chemical (ATC) Classification. DINOPROSTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dinoprostone under HS 29375000 and SITC 54156. As of Q4 2014, DINOPROSTONE remains the US FDA Preferred Term for this commodity. Dinoprostone bears US NLM identifiers UMLS ID C0012472 and NCI Concept Code C61727. SMILES: OC1C(C(C(=O)C1)C/C=C/CCCC(=O)O)/C=C/C(O)CCCCC.